Lactose is the most commonly used excipient in carrier-based dry powder inhalation (DPI)
formulations. Numerous inhalation therapies have been developed using lactose as a …

Lipid nanoparticles (LNPs) have emerged as a powerful non-viral carrier for drug delivery.
With the prevalence of respiratory diseases, particularly highlighted by the current COVID-19 …

Skin wounds have imposed serious socioeconomic burdens on healthcare providers and
patients. There are just more than 25,000 burn injury-related deaths reported each year …

Abstract A Dry Powder Inhaler (DPI) is a technique as well as a device used to inhale
formulation which is in the form of dry powder, and is inhaled through the nose or mouth. It …

Infectious lung diseases are inflammatory diseases of the lungs caused by infectious agents
such as bacteria, viruses or fungi. Oral or intravenous administration of antibiotics is the most …

This study developed a new dual delivery system of naringenin (NRG), a polyphenol, and
doxofylline (DOX), a xanthine derivative, as an inhaled microsphere system. In this system …

Pulmonary administration of dry powder formulation presents several advantages in the
treatment of respiratory diseases. Since micronized drug particles are very cohesive and …

The oral delivery system is very important and plays a significant role in increasing the
solubility of drugs, which eventually will increase their absorption by the digestive system …

Solid lipid nanoparticles (SLNs) are lipid-based colloidal systems used for the delivery of
active compounds. Although SLNs have many benefits, they show important issues due to …

Novel drug delivery system opens the doors towards nano/micro formulation strategies to
overcome the challenges associated with the poorly soluble and permeable drugs. Lipid …